| Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children (NCT00339040) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults (NCT00382980) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| ICATA Asthma Mechanistic Study (NCT00377390) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Islet Transplantation in Type 1 Diabetes (NCT00434811) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Congenital and Neonatal Malaria in Mali (NCT00384267) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Fetal Immunity to Falciparum Malaria (NCT00314899) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-15 |
| Effect of Albendazole Dose on Clearance of Filarial Worms (NCT00375583) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-09 |
| Experimental Vaccine for Prevention of Ebola Virus Infection (NCT00374309) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-05 |
| Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs (NCT00374517) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-05 |
| Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy (NCT00307164) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-01 |
| Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2) (NCT00371592) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-01 |
| Prospective Study of Infant Dengue (NCT00377754) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-01 |
| B-19 Parvovirus Vaccine Study (NCT00379938) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-08-01 |
| Development of Immune Globulin Treatment for Avian Flu (NCT00383071) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-08-01 |
| Mol Epi GrAS in Nicaragua (NCT00170521) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-08-01 |
| Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy (NCT00326482) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-31 |
| Investigation of Southern Tick-Associated Rash Illness (STARI) (NCT00358761) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-20 |
| Rheumatic Heart Disease Prevalence in Leon, Nicaragua (NCT00307112) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-13 |
| Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal (NCT00100568) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-01 |
| Rosiglitazone Effect on Mitochondria and Lipoatrophy (NCT00367744) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-01 |
| An Observational Study of Childhood Food Allergy (NCT00356174) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-01 |
| High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study (NCT00288626) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-01 |
| Malaria Prevalence in Children (NCT00322816) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-07 |
| Time to Infection With Malaria Parasites (NCT00322738) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-07 |
| Alternative Oseltamivir Dosing Strategies (NCT00334529) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-05 |
| Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (NCT00320606) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-05 |
| Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV (NCT00270296) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults (NCT00270699) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth (NCT00109590) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Cytomegalovirus Cell-Mediated Immunity (NCT00815165) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| CMV Infection in Adolescent Males (NCT00302029) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females (NCT00133497) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Urine Testing to Detect Kidney Transplant Rejection (NCT00337220) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults (NCT00333398) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Acute HIV Infection Observational Study (NCT00296660) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults (NCT00347672) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm (NCT00076817) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants (NCT00308412) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly (NCT00347555) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease (NCT00325078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes (NCT00324389) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Cidofovir in Renal Transplant Recipients With BKVN (NCT00138424) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People (NCT00078442) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (NCT00515047) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults (NCT00123968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study (NCT00346398) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Phase I Study of Vaccination Schedule of Experimental HIV Vaccines (NCT00321061) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-25 |
| Analysis of the Immune Response to the Malaria Parasite in Mali, West Africa (NCT00346346) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-17 |
| Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites (NCT00341666) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-03 |
| St. Jude Open Label H5 Trial (NCT00311675) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug (NCT00318747) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali (NCT00305123) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults (NCT00301184) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Bacterial Pulmonary Infection in PICU (NCT00271531) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications (NCT00433992) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Directly Observed Therapy for HIV Infected Adolescents (NCT00259389) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females (NCT00706368) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients (NCT00290823) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide (NCT00441909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study) (NCT00234091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| PsA Treatment With hOKT3γ1 (Ala-Ala) (NCT00239720) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-16 |
| Surveillance for Leishmaniasis Skin Lesions in Mali (NCT00344084) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-16 |
| SIGA-246 to Treat Smallpox (NCT00303225) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-13 |
| Phase I Study of West Nile Virus Vaccine (NCT00300417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-03 |
| Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis (NCT00438022) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| T and B Cell Response to Avian Flu Vaccine (NCT00337896) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant (NCT00320658) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients (NCT00308802) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| H5 Vaccine Alone or With Adjuvant in Healthy Adults (NCT00296634) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults (NCT00294099) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy (NCT00099632) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Use of Infliximab for the Treatment of Pemphigus Vulgaris (NCT00283712) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China (NCT00479141) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection (NCT00183261) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies (NCT00307125) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Rift Valley Fever in Kenya (NCT00287014) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Prevalence of HIV and Other Sexually Transmitted Infections Among Female Sex Workers and Miners in Honghe Prefecture, Yunnan Province, China (NCT00278499) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Safety and Dose Study of Peramivir for Influenza Treatment (NCT00297050) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-23 |
| Effect of Albendazole Dose on Clearance of Filarial Worms (NCT00339417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-22 |
| Study of Factors Involved in Resistance to Severe Malaria (NCT00368810) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-21 |
| Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa (NCT00341393) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-16 |
| Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda (NCT00342160) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-15 |
| Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children (NCT00260078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs (NCT00257127) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| H5 Adult - Chiron Study of Bird Flu Vaccine (NCT00280033) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza (NCT00298233) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| TY800 Dose Escalation (Typhoid) (NCT00269295) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| CVD 909 Vi Prime Boost Study (NCT00326443) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults (NCT00270218) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy (NCT00286767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Voriconazole Blood Levels and Toxicity (NCT00359541) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-19 |
| Malaria Vaccine in Children in Mali (NCT00341250) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-19 |
| Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research (NCT00277849) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-11 |
| Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART (NCT00270205) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults (NCT00141024) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| Increasing Condom Use in People at Risk for HIV Infection (NCT00080093) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| Incidence of Group A Strep Pharyngitis in School Children in Fiji (NCT00284882) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| Prevalence of RHD, Pyoderma and Scabies in Children in Fiji (NCT00284843) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| A/H5N1 Vaccine in Healthy Children Aged 2-9 Years (NCT00133536) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients (NCT00270465) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-21 |